Antifibrotic Properties of Relaxin: In Vivo Mechanism of Action in Experimental Renal Tubulointerstitial Fibrosis
Tim D. Hewitson(The Royal Melbourne Hospital), Chrishan S. Samuel(Monash University)
Cited by 72
Related Papers
Relaxin Signals through a RXFP1-pERK-nNOS-NO-cGMP-Dependent Pathway to Up-Regulate Matrix Metalloproteinases: The Additional Involvement of iNOS
|PLoS ONE|2012|129
FGF23 is synthesised locally by renal tubules and activates injury-primed fibroblasts
|Scientific Reports|2017|92
AT1R-AT2R-RXFP1 Functional Crosstalk in Myofibroblasts: Impact on the Therapeutic Targeting of Renal and Cardiac Fibrosis
|Journal of the American Society of Nephrology|2019|49
Epigenetic Modifications to H3K9 in Renal Tubulointerstitial Cells after Unilateral Ureteric Obstruction and TGF-β1 Stimulation
|Frontiers in Pharmacology|2017|48